15th of January Nansen Neuroscience Network organized an information meeting about The National Association for Public Health's dementia research program. During the TV fundraiser in October, 229 million NOK was raised for the association's work on dementia. 80 million NOK will be used for research purposes. 

Reports from HelseOmsorg21’s five working groups are available on their website. The comment period closes on 17th January 2014. The review period allows individuals and groups to examine a draft version of the reports and provide comments aimed at improving it.  

The 11th call for the EU programme Innovative Medicines Initiative (IMI) was launched today. Of the eight topics, one is of particular interest for NNN members: European platform for proof of concept for prevention in Alzheimer’s Disease. 

The health cluster organisations Oslo Cancer Cluster, Oslo Medtech and Nansen Neuroscience Network propose the exploration of a new financial instrument to stimulate innovation in health care.   

The European initiative ERASysAPP is launching its first joint call to promote research projects that are application-oriented and/or industry-relevant.

Pre Diagnostics AS is a new Alzheimer’s disease (AD) diagnostics company based on Akershus University Hospital’s (AHUS) research. 

Our member company Smartfish was profiled in this Friday’s sports-extra of Finansavisen. 

NNN, The Norwegian Research Council, Oslo Medtech and Oslo Cancer Cluster hosted information meeting on Horizon 2020, IMI and AAL on November 25th. In Oslo Science Park Norwegian Research Council shared the latest on these programmes.